批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/11/21 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/11/09 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/04/28 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/05/03 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/05/09 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/06/21 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/01/18 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/04/10 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/01/25 |
SUPPL-16(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2002/01/25 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/09/08 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/02/22 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/01/06 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/01/06 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/01/06 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/01/06 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1997/05/08 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/09/10 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/06/13 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/06/11 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/11/03 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1995/04/06 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1995/02/22 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/12/27 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1993/04/02 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1992/10/29 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:OXAPROZIN 剂型/给药途径:TABLET;ORAL 规格:600MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
018841 |
004 |
NDA |
DAYPRO |
OXAPROZIN |
TABLET;ORAL |
600MG |
Prescription |
Yes |
Yes |
AB |
1992/10/29
|
PFIZER |
075845 |
001 |
ANDA |
OXAPROZIN |
OXAPROZIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB |
2001/01/31
|
PANGEA |
075855 |
001 |
ANDA |
OXAPROZIN |
OXAPROZIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB |
2001/01/31
|
DR REDDYS LABS LTD |
075849 |
001 |
ANDA |
OXAPROZIN |
OXAPROZIN |
TABLET;ORAL |
600MG |
Discontinued |
No |
No |
AB |
2002/07/03
|
TEVA |
075987 |
001 |
ANDA |
OXAPROZIN |
OXAPROZIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB |
2004/09/02
|
CHARTWELL |
208633 |
001 |
ANDA |
OXAPROZIN |
OXAPROZIN |
TABLET;ORAL |
600MG |
Prescription |
No |
No |
AB |
2017/05/04
|
AMNEAL PHARMS CO |